Anna Dąbrowska‐Iwanicka

Statistics

Publications

Citations

650

H-Index

Active since

1997

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Medical University of Warsaw

University Hospital Brno

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Central Clinical Hospital

Anna Dąbrowska‐Iwanicka is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

1997–2024

Publications

Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Dominika Nowis, Michał Mączewski, Urszula Mackiewicz et al. · American Journal Of Pathology · 2010 · 136 citations · Full text

Medicine, Oncology, Pharmacology +12

Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20

Magdalena Winiarska, Jacek Bil, Ewa Wilczek et al. · PLoS Medicine · 2008 · 122 citations · Full text

Medicine, Immunology, Pharmacology +17

Lovastatin and tumor necrosis factor-? exhibit potentiated antitumor effects against Ha-ras-transformed murine tumorVia inhibition of tumor-induced angiogenesis

Wojciech Feleszko, Ewa Z. Ba kowiec, Elisabeth Sieberth et al. · International Journal of Cancer · 1999 · 93 citations

Medicine, Oncology, Pharmacology +11

Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice

Witold Lasek, Wojciech Feleszko, Tomasz Stokłosa et al. · Cancer Immunology Immunotherapy · 1997 · 67 citations · Full text

Life Sciences, Immunology, Oncology +16

Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity

Jacek Bil, Magdalena Winiarska, Dominika Nowis et al. · Blood · 2010 · 45 citations

Life Sciences, Immunology, Oncology +14

1–5 of 13